You are here
The European Journal of Cancer (EJC) is an international multidisciplinary oncology journal. EJC publishes original research, reviews and editorial comments on a wide range of oncology disciplines, including basic and preclinical cancer research, translat
In addition to research and reviews, every month the journal also publishes EJC News Focus, a series of video interviews with key opinion leaders in oncology.
The EJC is included in the leading abstracting and indexing services, such as PubMed/MEDLINE, Current Contents/Clinical Medicine, the Science Citation Index, the Journal Citation Reports and Scopus.
The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR) and the European Society of Breast Cancer Specialists (EUSOMA).
Publishing in EJC
EJC provides authors with a number of benefits. Efficient peer-review contributes to fast publication times, with all manuscripts accepted for publication being published online – citable and indexed – within four to five weeks of acceptance. Authors can also enhance their articles with a number of Content Innovations, including AudioSlides, the Database Linking Tool and Gene Expression Omnibus Linked Data.
Published in print and online, the EJC is available to more than 17,000 academic and clinical institutions, personal subscribers and members of the journal's Society Partners.
Readers can also access EJC via an iPad app and sign up for free eTables of Contents via email, which are sent out for each issue of the journal.